Stemson Therapeutics Announces Additions To Its Scientific Advisory Board
Stemson Therapeutics announced today the addition of Kapil Bharti, Ph.D. and George Murphy, M.D. to its Scientific Advisory Board. The addition of these distinguished leaders in the field significantly bolster Stemson’s efforts to restore human hair growth with a novel cell regeneration technology using the patient’s own cells to generate new hair follicles. Dr. Bharti is a Senior Investigator at the National Eye Institute at the National Institutes of Health and is a world renowned expert in regenerative medicine, stem cell biology, and developmental biology of the eye. Dr. Murphy is Co-Director of the Harvard Stem Cell Institute Skin Program, Professor of Pathology at Harvard Medical School, and the Director of the Program in Dermatopathology at the Brigham and Women’s Hospital.